Physician profile
Sean Michael Cook
NPI 1275584344
$2,234.57
in general payments reported to CMS, 2019-2025
18 companies · $710 in 2025
The $710 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $129 · 2021: $109 · 2022: $308 · 2023: $264 · 2024: $446 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $821.07 | 2019-2025 | Airsupra, Breztri, Andexxa |
| Novo Nordisk INC | $466.16 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $221.01 | 2021-2025 | Ubrelvy |
| Lilly USA, LLC | $214.24 | 2019-2025 | Zepbound, Mounjaro |
| Abbott Laboratories | $95.37 | 2021-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $80.78 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $61.79 | 2022-2023 | Arexvy, Shingrix |
| Pfizer INC. | $45.51 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.45 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $43.80 | 2019-2025 | Gardasil 9, Capvaxive |
| Seqirus USA INC | $28.39 | 2025 | Fluad, Flucelvax |
| Bayer Healthcare Pharmaceuticals INC. | $21.68 | 2025 | |
| Sanofi Pasteur INC. | $17.90 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $15.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.94 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $13.97 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.83 | 2024 | Eliquis |
| Amarin Pharma, INC. | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.